Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up1.00% Nasdaq Up1.29%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS
54.61 1.39(2.61%) Apr 16, 4:00PM EDT
|After Hours : 54.61 0.00 (0.00%) Apr 16, 4:48PM EDT
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 16, 2014Pechala's ReportsLubomir PechalaALNYLAM PHARMACEUTICALS INC (ALNY) - REPORT FOR ACTIVE TRADERS1$25
Apr 15, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49
Apr 11, 2014Alpha Street ResearchHunter OrrALNY - Alnylam Pharmaceuticals Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report9$24
Apr 11, 2014S&P Capital IQ – STARS ReportsN/AAlnylam Pharmaceuticals11$126.50
Apr 11, 2014Pechala's ReportsFrantisek PechalaALNYLAM PHARMACEUTICALS INC (ALNY) 12-months forecast1$15
Apr 10, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: ALNY , DVAX , IBIO , PTN , SGEN , SNMX -- DRUGS3$34.50
Apr 10, 2014Ford Investor Services, Inc.N/AValue Graph: ALNYLAM PHARM -- ALNY1$11.50
Apr 10, 2014Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALNYLAM PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20
Apr 9, 2014ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for ALNY11$25
Apr 5, 2014TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ALNYLAM PHARMACEUTICALS INC (ALNY)5$10

View All Reports for ALNY ...